A thorough analysis of tumor biopsies taken during treatment revealed substantial immunomodulatory effects, including viral replication, the infiltration of CD8+ T cells and NK cells interacting with PD-L1+ cells, and a reduction in peripheral Tregs, among patients who benefited from the therapy [165]. The gene discussed is CD8A; the disease is neoplasm.